Related Experiment Video
Updated: May 18, 2026
07:43
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Pituitary surgery: experience from a large network in Central Switzerland
Sven Berkmann1, Javier Fandino, Beat Müller
1Department of Neurosurgery, Kantonsspital Aarau, Switzerland. sven.berkmann@bluewin.ch
Swiss Medical Weekly
|October 6, 2012
Summary
Pituitary surgery in a Swiss network improved outcomes, with intraoperative MRI significantly increasing resection rates. Close collaboration between specialized centers optimizes patient care and follow-up for pituitary tumors.
Area of Science:
- Neurosurgery
- Endocrinology
- Oncology
Background:
- Established a Swiss-wide care network for pituitary tumor patients, serving approximately 1.6 million inhabitants.
- Retrospective observational study analyzing longitudinal data from a large patient cohort.
Purpose of the Study:
- To review the surgical experience and outcomes for patients with pituitary tumors within a specialized Swiss network.
- Evaluate the effectiveness of surgical interventions and identify factors influencing patient outcomes.
Main Methods:
- Included 182 patients who underwent surgery at the Neurosurgical Department of Kantonsspital Aarau between 2005-2010.
- Utilized intraoperative MRI (iMRI) in 63% of cases; follow-up duration averaged 3.6 years.
Main Results:
- Common lesions included non-functioning adenomas (63%), macroprolactinomas (10%), and Rathke's cleft cysts (5%).
- Preoperative hypopituitarism affected 58% of patients, with 48% showing postoperative recovery of endocrine axes.
- iMRI use significantly increased gross total resection rates (p=0.0007), and 89% of patients with visual deficits experienced recovery.
Conclusions:
- Transsphenoidal surgery is the primary treatment for most sellar lesions, with iMRI enhancing resection rates.
- Close cooperation between specialized Swiss centers positively impacts surgical caseloads and patient follow-up.
- The study highlights the benefits of a collaborative, network-based approach to pituitary tumor management.
